Cynata Therapeutics Limited has released a press release.
June 2026 Quarterly Activity Report & Appendix 4C
Earlier from Cynata Therapeutics
- Board, Management Changes, Expenditure Reductions, RDTI Loan
- Reinstatement to Official Quotation
- CYP-001 GvHD Trial Primary Evaluation Results
- Suspension from Quotation